Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome

„Humoral autoimmunity may contribute to cognitive impairment in post-COVID-19 syndrome“.

The majority of Long COVID patients with cognitive impairment may have CNS autoantibodies as reported in a study led by Charité – Universitätsmedizin Berlin and published recently in „Brain, Behavior, and Immunity„.

Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome – ScienceDirect

  • Schlagwörter

Ähnliche Beiträge